GLP-1 therapies are reshaping obesity, diabetes, and even cardiovascular care Demand has outpaced global manufacturing capacity A grey market has emerged and regulators are now stepping in to contain it Patients want affordable, available treatment
GLP-1 receptor agonists are generally discontinued before planned conception according to labeling, and phentermine-topiramate has specific fetal toxicity risk because of topiramate-associated oral clefts
Insurance formulary changes, prior authorization denials, or financial hardship may force discontinuation regardless of clinical appropriateness
Whos Eligible and How to Get Started GLP-1 Essentials from TRC Healthcare is designed for a wide range of healthcare professionals looking to confidently manage GLP-1 therapy, including: Pharmacists Pharmacy Technicians Physicians Physician Assistants (PAs) Nurse Practitioners (NPs) Nurses Whether youre counseling patients in the community or supporting decisions across a broader team, GLP-1 Essentials equips you with the clinical knowledge and confidence to lead
Generic semaglutide may be available sooner than 2031 outside the U.S
